Gilead Sciences
Explore the latest on Gilead Sciences, a leader in innovative HIV prevention, including FDA approvals and developments in affordable, long-acting treatments.
![Two Annual Injections to Prevent HIV: FDA Approves $40 Generic Version]()
Two Annual Injections to Prevent HIV: FDA Approves $40 Generic Version
Published on 11/2/2026
